Cargando…
Commercial Low Molecular Weight Heparins — Patent Ecosystem and Technology Paradigm for Quality Characterization
Heparin is a subject of ever-growing interest for laboratory researchers and pharmaceutical industry. One of the driving factors is its critical life-saving drug status, which during the COVID-19 pandemic has assumed a central role in disease treatment and/or prevention. Apart, heparin is one amongs...
Autores principales: | Iqbal, Zarina, Sadaf, Saima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330979/ https://www.ncbi.nlm.nih.gov/pubmed/35915630 http://dx.doi.org/10.1007/s12247-022-09665-7 |
Ejemplares similares
-
Weight stigma is overlooked in commercial‐grade mobile applications for weight loss and weight‐related behaviors
por: Olson, KayLoni L., et al.
Publicado: (2020) -
How to promote the accessibility of technology in the era of hESC patents—A comparative analysis of the systems of the US and China
por: Zhang, Wei, et al.
Publicado: (2023) -
Animal immunization merges with innovative technologies: A new paradigm shift in antibody discovery
por: Prabakaran, Ponraj, et al.
Publicado: (2021) -
Analysis of the Utilization and Prospects of CRISPR-Cas Technology in the Annotation of Gene Function and Creation New Germplasm in Maize Based on Patent Data
por: Wang, Youhua, et al.
Publicado: (2022) -
Heparins: A Shift of Paradigm
por: Hemker, H. Coenraad, et al.
Publicado: (2019)